| Financial Year |
March 31 2023 |
| Monetary Funds |
2,500,359,388.31 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
661,448,827.00 |
| Advances to Suppliers |
306,268,073.61 |
| Other Receivables |
65,195,819.96 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
906,587,933.16 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,889,369,616.06 |
| Total Current Assets |
7,116,062,261.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,004,244,937.13 |
| Investment Properties |
511,038.02 |
| Fixed Assetes |
4,418,962,366.29 |
| Under-construction Projects |
702,157,924.95 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,070,613,767.09 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,021,317,343.31 |
| Deferred Income Tax Assets |
396,437,251.90 |
| Other Non-Current Assets |
78,883,166.75 |
| Sub-Total of Non-Current Assets |
9,808,501,200.11 |
| Total Assets |
16,924,563,461.50 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,000,000.00 |
| Accounts Payable |
723,446,304.66 |
| Accounts Received In Advance |
1,886,358.38 |
| Employee Compensation Payable |
87,017,709.39 |
| Taxes Payable |
389,371,832.08 |
| Interest Payable |
-- |
| Dividend Payable |
38,500,000.00 |
| Other payables |
214,150,849.50 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
35,178,646.14 |
| Other Current Liabilities |
12,731,286.79 |
| Sub-Total of Current Liabilities |
1,629,370,008.71 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
314,960,883.08 |
| Deferred Income Tax Liabilities |
30,088,277.39 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
615,276,028.86 |
| Total Liabilities |
2,244,646,037.56 |
| Paid-In Capital(Or Share Stock) |
3,226,604,400.00 |
| Capital Surplus |
6,753,545,722.08 |
| Surplus Reserve |
1,029,878,495.25 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,779,043,387.25 |
| Minority Stockholder's Interest |
662,341,943.71 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
14,017,575,480.23 |
| Owner's Equity（Stockholder's Equity） |
14,679,917,423.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
16,924,563,461.50 |
